Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class ASSE: 603139

"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Shareholding Reduction Plan by Shareholders Holding More Than 5% of the Shares and Directors

Sep 16, 2026 · Issued by Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Sep 16, 2026

Announcement on Shareholding Reduction Plan by Shareholders Holding More Than 5% of the Shares and Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A

"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 5th Extraordinary General Meeting in 2026Sep 8
"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Completion of Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares and Results of Shareholding ReductionSep 2
"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Key Operating Data for the First Half of 2026Aug 29
"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Progress in Providing Guarantee for Wholly-owned SubsidiaryAug 28

All Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A news releases